NCCN guidelines® insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelines

Arnel Pallera, Jessica K. Altman, Ellin Berman, Camille N. Abboud, Bhavana Bhatnagar, Peter Curtin, Daniel J. DeAngelo, Jason Gotlib, R. Tanner Hagelstrom, Gabriela Hobbs, Madan Jagasia, Hagop M. Kantarjian, Patricia Kropf, Leland Metheny, Joseph O. Moore, Evelena Ontiveros, Enkhtsetseg Purev, Albert Quiery, Vishnu V.B. Reddy, Michal G. RoseNeil P. Shah, B. Douglas Smith, David S. Snyder, Kendra L. Sweet, Raoul Tibes, David T. Yang, Kristina Gregory, Hema Sundar, Michael Deininger, Jerald P. Radich

Research output: Contribution to journalReview articlepeer-review

44 Scopus citations

Abstract

The NCCN Guidelines for Chronic Myeloid Leukemia (CML) provide recommendations for the management of chronic-phase and advanced-phase CML in adult patients. The median age of disease onset is 67 years. However, because CML occurs in all age groups, clinical care teams should be prepared to address issues relating to fertility and pregnancy with patients who are of reproductive age at the time of diagnosis. CML is relatively rare in children and there are no evidence-based recommendations for the management of CML in pediatric population. These NCCN Guidelines Insights discuss special considerations for the management of CML during pregnancy and for the management of CML in the pediatric population.

Original languageEnglish (US)
Pages (from-to)1505-1512
Number of pages8
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume14
Issue number12
DOIs
StatePublished - Dec 1 2016

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'NCCN guidelines<sup>®</sup> insights: Chronic myeloid leukemia, version 1.2017: Featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

Cite this